Elixirr International Grants Share Options to Key Executives

Elixirr International Plc ( (GB:ELIX) ) has issued an update.

Elixirr International plc has announced the grant of share options to key managerial figures, Clare Filby and Christopher Jordan, as part of its unapproved share option plan. These options, which cover a total of 119,048 ordinary shares each, represent approximately 0.49% of the company’s issued share capital and are set at an exercise price of 840p per share with a five-year vesting period. This move is indicative of Elixirr’s strategy to incentivize its leadership team, potentially enhancing its market position and aligning managerial interests with shareholder value.

The most recent analyst rating on (GB:ELIX) stock is a Buy with a £850.00 price target. To see the full list of analyst forecasts on Elixirr International Plc stock, see the GB:ELIX Stock Forecast page.

Spark’s Take on GB:ELIX Stock

According to Spark, TipRanks’ AI Analyst, GB:ELIX is a Outperform.

Elixirr International Plc receives a strong overall score due to its robust financial performance and positive corporate events, indicating growth potential and strategic positioning. While technical indicators show mixed signals, they do not significantly detract from the company’s sound fundamentals and valuation, which are moderate yet fair.

To see Spark’s full report on GB:ELIX stock, click here.

More about Elixirr International Plc

Elixirr International plc is a global consulting firm known for its innovative approach to consultancy, challenging traditional methods by working collaboratively with clients across various industries and geographies. Since its founding in 2009, Elixirr has expanded its capabilities through the acquisition of several boutique firms and has been listed on the AIM market of the London Stock Exchange since 2020.

Average Trading Volume: 99,010

Technical Sentiment Signal: Buy

Current Market Cap: £374.6M

See more insights into ELIX stock on TipRanks’ Stock Analysis page.